Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

bioAffinity Technologies (BIAF) Convertible Debt (2022)

Historic Convertible Debt for bioAffinity Technologies (BIAF) over the last 1 years, with Q4 2022 value amounting to $325000.0.

  • bioAffinity Technologies' Convertible Debt changed N/A to $325000.0 in Q4 2022 from the same period last year, while for Dec 2022 it was $325000.0, marking a year-over-year change of. This contributed to the annual value of $325000.0 for FY2022, which is N/A changed from last year.
  • According to the latest figures from Q4 2022, bioAffinity Technologies' Convertible Debt is $325000.0.
  • In the past 5 years, bioAffinity Technologies' Convertible Debt ranged from a high of $2.6 million in Q3 2022 and a low of $325000.0 during Q4 2022